BRUSSELS (Reuters) - The European Commission said Germany's Bayer <BAYGn.DE> had submitted commitments aimed at easing competition concerns over its $66 billion takeover of U.S. agrochemicals group Monsanto <MON.N>, suggesting the company aims to avoid a lengthy review.
The Commission said it had extended a deadline by two weeks, aiming to complete its initial review of the deal by Aug. 22.
The German chemicals maker has previously agreed to major asset sales to win the go-ahead from competition authorities, though it did not comment on Tuesday on what it had offered to the European Commission.
- PHOTOS: New art and old relics at Mickey Mouse's NYC gallery 25 Pictures
- PHOTOS: See Yes on 3 supporters react to historic transgender rights Question 3 win 11 Pictures
- PHOTOS: A look back at Queen performing in the 1970s and 1980s 22 Pictures
- All of these celebrities have had their nudes leaked 35 Pictures
- PHOTOS: A look at Idris Elba's style through the years 20 Pictures
- PHOTOS: Heidi Klum's annual Halloween party and other amazing celebrity costumes 17 Pictures
- These are the spookiest cities per capita in the U.S. 5 Pictures
- Food Network star talks pumpkin carving 1 Pictures
- Who is Alexander Edwards, Amber Rose's new boyfriend? 9 Pictures
- Is Cardi B pregnant again? This tweet has people guessing 6 Pictures
- Natural Museum's best wildlife photos of the year 5 Pictures
It still expects to be able to close the deal by year-end.
Recent deals in the sector, such as the merger of Dow Chemical <DOW.N> and DuPont and ChemChina's purchase of Switzerland's Syngenta, were subjected to full-scale probes, resulting in substantial concessions from the companies.
(Reporting by Elizabeth Miles and Robert-Jan Bartunek; additional reporting by Ludwig Burger; editing by Jason Neely and David Evans)